Evidence map›Paper›PMID 33512778›Full record

Trial reportCancer medicine2021

Which is preferred for initial treatment of papillary thyroid cancer, total thyroidectomy or lobotomy?

Zhen Wu, Lin Han, Wenlei Li, Wei Wang, Liqaing Chen, Yumin Yao, Yongkun Wang

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. [A nomogram combining ultrasound radiomics and clinical features for predicting pathological invasiveness of papillary thyroid carcinoma].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zhen WuDepartment of Thyroid Surgery, Liaocheng People's Hospital, Clinical Hospital of Shandong First Medical University, Liaocheng, China.
Lin HanDepartment of Pathology, Liaocheng People's Hospital, Clinical Hospital of Shandong First Medical University, Liaocheng, China.
Wenlei LiDepartment of Thyroid Surgery, Liaocheng People's Hospital, Clinical Hospital of Shandong First Medical University, Liaocheng, China.
Wei WangDepartment of Thyroid Surgery, Liaocheng People's Hospital, Clinical Hospital of Shandong First Medical University, Liaocheng, China.
Liqaing ChenDepartment of Thyroid Surgery, Liaocheng People's Hospital, Clinical Hospital of Shandong First Medical University, Liaocheng, China.
Yumin YaoDepartment of Thyroid Surgery, Liaocheng People's Hospital, Clinical Hospital of Shandong First Medical University, Liaocheng, China.
Yongkun WangDepartment of Thyroid Surgery, Liaocheng People's Hospital, Clinical Hospital of Shandong First Medical University, Liaocheng, China.ORCID 0000-0001-5705-8674
Liaocheng People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposesThe incidence of thyroid cancer has increased annually, and has a heavy psychological and economic burden on society and individuals. Based thyroid cancer data from patients treated in Liaocheng People's Hospital from 2015 to 2018, with Chinese national and regional characteristics, in this study, we addressed the controversy of which initial thyroid surgical mode, lobectomy or total thyroidectomy, is most effective.

methodsClinical and pathological data from 2108 patients with thyroid cancer, who were initially diagnosed and treated surgically, were collected from the Department of Thyroid Surgery. Among them, there were 1001 cases who underwent open operation with total thyroidectomy + central lymph node dissection; meanwhile, 1107 cases were treated with neck lateral lymph node dissection at the same time.

resultsThe overall metastasis rate of all patients was 57.23%. Even the lymph node metastasis of papillary thyroid microcarcinoma (PTMC) was as high as 48.97%. When the mass rose above 2 cm, the proportion of metastasis increased to 77.22%. When the tumor was complicated with bilateral and multiple high-risk factors, the proportion of metastasis was 65.27% and 72.21%, respectively. When the tumor breaks through the capsule, the metastasis rate was 67.08%. With the increase of tumor diameter, the metastasis of cervical lymph nodes ranged from 22.54% to 73.33%, which showed positive correlation. 49.32% of patients had lymph node metastasis in the lateral cervical region. When the diameter of the tumor reached T1c level, the metastasis of the cervical lymph nodes was 56.91%, and the number of metastatic cases above T1c level accounted for 69.96% of the total metastatic cases.

conclusionThe degree of malignancy of thyroid cancer depends on tumor genome evolution. Rates of neck lymph node metastasis are high, particularly among patients with risk factors for poor prognosis. It is recommended that initial treatment should comprise at least total thyroidectomy + central lymph node dissection in China, to avoid the risks associated with secondary surgery and effects on patient quality of life. When the tumor diameter exceeds 1 cm, the risk of cervical lymph node metastasis is high, and we recommended lateral lymph node dissection.

Indexed as

AdolescentAdultAgedCarcinoma, PapillaryFemaleHumansLymphatic MetastasisLymph Node ExcisionMaleMiddle AgedNeckRetrospective StudiesRisk FactorsThyroid Cancer, PapillaryThyroidectomyThyroid Glandinitial treatmentmetastasissurgerythyroid cancer

Identifiers

PMID33512778
PMCPMC7940239
OpenAlexW3196897406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.